Your browser doesn't support javascript.
loading
Humoral response and safety of the BNT162b2 and mRNA-1273 COVID-19 vaccines in patients with haematological diseases treated with anti-CD20 antibodies: An observational study.
Nishikubo, Masashi; Shimomura, Yoshimitsu; Maruoka, Hayato; Nasu, Seiko; Nishioka, Tomomi; Sakizono, Kenji; Mitsuyuki, Satoshi; Kubo, Tomoyo; Okada, Naoki; Nakagawa, Daishi; Kamijo, Kimimori; Imoto, Hiroharu; Yamamoto, Ryusuke; Nagai, Yuya; Hiramoto, Nobuhiro; Yoshioka, Satoshi; Yonetani, Noboru; Matsushita, Akiko; Miyakoshi, Chisato; Doi, Asako; Ishikawa, Takayuki.
Afiliación
  • Nishikubo M; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Shimomura Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Maruoka H; Department of Environmental Medicine and Population Science, Graduate School of Medicine, Osaka University, Osaka, Japan.
  • Nasu S; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nishioka T; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Sakizono K; LSI Medience Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Mitsuyuki S; Department of Clinical Laboratory, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kubo T; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Okada N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nakagawa D; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Kamijo K; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Imoto H; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yamamoto R; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Nagai Y; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Hiramoto N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yoshioka S; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Yonetani N; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Matsushita A; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Miyakoshi C; Department of Hematology, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Doi A; Department of Research Support, Center for Clinical Research and Innovation, Kobe City Medical Center General Hospital, Kobe, Japan.
  • Ishikawa T; Department of Infectious Diseases, Kobe City Medical Center General Hospital, Kobe, Japan.
Br J Haematol ; 197(6): 709-713, 2022 06.
Article en En | MEDLINE | ID: mdl-35262920
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Enfermedades Hematológicas Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Japón
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: COVID-19 / Enfermedades Hematológicas Tipo de estudio: Observational_studies Límite: Humans Idioma: En Revista: Br J Haematol Año: 2022 Tipo del documento: Article País de afiliación: Japón